Suscribirse

TUBERCULOSIS IN CHILDREN - 11/09/11

Doi : 10.1016/S0095-4543(05)70367-5 
Jeffrey R. Starke, MD *

Resumen

Despite the existence of curative therapy for disease, effective treatment for infection, and the fact that the bacillus Calmette-Guerin (BCG) vaccination has been given to approximately 4 billion people, Mycobacterium tuberculosis remains the single pathogen causing the most disease and death in the world today. The World Health Organization (WHO) has estimated that during the 1990s, there will be 90 million cases of tuberculosis and 30 million deaths caused by tuberculosis throughout the world.44 Approximately 15 million cases and 4.5 million deaths will occur among children.33 The true tragedy of tuberculosis is that the medical tools exist to address the problem, yet they have not reached the people most in need of them.

Many industrialized countries, including the United States, have experienced a resurgence of tuberculosis during the past 10 years. Although the burden of infection and disease has been far less in these countries than in the developing world, this resurgence has received attention because it reflects a weakening of the public health system in these countries. The pool of persons infected with M. tuberculosis in the United States has increased dramatically during the past decade. Many primary care practitioners who previously had little experience with tuberculosis-related issues now find themselves facing these problems fairly regularly.

The purpose of this article is to address tuberculosis from the point of view of the busy primary care practitioner who cares for children in the United States. During the past few years, the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP)2, 3, 4, 5 have issued many new and, at times, seemingly conflicting recommendations about the evaluation and testing of children for tuberculosis infection and disease. Although these recommendations are based on good science and public health principles, they are sometimes difficult to apply in an office practice. With some fairly simple changes in approach,

however, the primary care practitioner can address tuberculosis-related issues in a fairly simple and straightforward manner.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Jeffrey R. Starke, MD Texas Children's Hospital MC 3-2371 1102 Bates Street Houston, TX 77030
Dr. Starke is supported in part by the National Heart, Lung, and Blood Institutes of Health, NIH, grant number 5K07 HL03032-03.


© 1996  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 23 - N° 4

P. 861-881 - décembre 1996 Regresar al número
Artículo precedente Artículo precedente
  • AFEBRILE PNEUMONIA IN INFANTS
  • Gregory P. DeMuri
| Artículo siguiente Artículo siguiente
  • EVALUATION OF PERSISTENT COUGH IN CHILDREN
  • Albert A. Meyer, Paul V. Aitken

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.